百济神州前三季度再亏36亿元,现金流持续告负、用14.67亿元超募资金补流

消费日报网
22 Nov 2024

作为一家专注于研发创新抗肿瘤药物的医药公司,百济神州至今尚未盈利,高企的费用支出也在持续带来现金流压力。据披露,前三季度,公司经营活动产生的现金流量净额约为-18.41亿元。随三季报一同发布的,还有百济神州拟使用部分超募资金4.89亿元用于永久补充流动资金的公告。据梳理,这是百济神州2022年来第三次使用超募资金补流,三次资金累计达14.67亿元。费用高企 深陷亏损公开资料显示,百济神州成立于...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10